diagnostica

GeneSys Bio comprises a team of four individuals with the mission of revolutionizing the diagnosis of infective diseases and resistance to antibiotics.

FLIM LABS is an Italian startup active in the fields of the fluorescence lifetime spectroscopy and imaging (FLIM).

The company, founded in 2019, is focused on the development of portable plug-n-play instrumentation and AI-driven software to simplify and encourage the mass-scale adoption of fluorescence lifetime-based techniques.

Cellply is a biotechnology company that develops scientific tools automating cell-based functional assays whose aim is to deeply characterize the mode of action of both approved and novel anti-cancer drugs, being able to evaluate the heterogeneity in function of both immune and tumor cells with a single-cell resolution.